Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 1.000 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.618 | |
| 2c0t | L3G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.607 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.581 | |
| 3vs4 | VSF | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.570 | |
| 3vs1 | VSA | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.555 | |
| 2c0o | L2G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.551 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.538 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.537 | |
| 3vs6 | VSH | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.537 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.536 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.531 | |
| 3bbt | FMM | Receptor tyrosine-protein kinase erbB-4 | 2.7.10.1 | 0.530 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.522 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.516 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.509 | |
| 3vry | B43 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.490 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.486 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.485 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.479 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.479 | |
| 4i22 | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.476 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.473 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.472 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 5ajq | DB8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.466 | |
| 3poz | 03P | Epidermal growth factor receptor | 2.7.10.1 | 0.462 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.460 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.460 | |
| 3w2r | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.459 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.458 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.455 | |
| 3w18 | N13 | Aurora kinase A | 2.7.11.1 | 0.451 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.450 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.450 | |
| 1xkk | FMM | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
| 4l7s | G7K | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.448 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.441 |